ResearcherInsermActive in the last 2 years
Magali Svrcek
Matched on ORCID iD 0000-0001-9023-5791; OpenAlex author ID A5010902289. Sources: OpenAlex.
Their work
- Papers
- 22 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 67
2012: 2 papers · 2013: 2 papers · 2014: none · 2015: 3 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers · 2020: none · 2021: 6 papers · 2022: 2 papers · 2023: 2 papers · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 22
- The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer. Co-author DOI 10.1016/s1470-2045(25)00714-4↗
- Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41591-023-02790-x↗
- Trop-2 is a ubiquitous and promising target in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.clinre.2023.102108↗
- Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma. Co-author DOI 10.1038/s41467-023-39026-y↗
- Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict adjuvant chemosensitivity in pancreatic c… Co-author DOI 10.1016/j.tranon.2021.101315↗
- PACpAInt: a deep learning approach to identify molecular subtypes of pancreatic adenocarcinoma on histology slides Co-author DOI 10.1101/2022.01.04.474951↗
- A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.annonc.2020.10.601↗
- Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resected pancreatic adenocarcinoma. Co-author DOI 10.1016/j.ejca.2021.01.042↗
- Prognostic Relevance of Pancreatic Adenocarcinoma Whole-Tumor Transcriptomic Subtypes and Components. Co-author DOI 10.1158/1078-0432.ccr-21-1907↗
- Ovarian metastases of pancreatic adenocarcinoma: clinical presentation, role of surgery, and potential value of the mutational profile for the differential dia… First author DOI 10.1177/17588359211053412↗
- Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features. Co-author DOI 10.3390/cancers13061234↗
- Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcom… Last author DOI 10.3390/ijms22136756↗
- Pancreatic ductal adenocarcinoma harboring microsatellite instability / DNA mismatch repair deficiency. Towards personalized medicine. Last author DOI 10.1016/j.suronc.2018.11.019↗
- hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status. Co-author DOI 10.3390/cancers11111808↗
- Lysyl oxidase family activity promotes resistance of pancreatic ductal adenocarcinoma to chemotherapy by limiting the intratumoral anticancer drug distribution. Co-author DOI 10.18632/oncotarget.8527↗
- Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000000394↗
- Human equilibrative nucleoside transporter 1 testing in pancreatic ductal adenocarcinoma: a comparison between murine and rabbit antibodies. Co-author DOI 10.1111/his.12577↗
- Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-14-0667↗
- S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.ejca.2013.04.017↗
- Number of examined lymph nodes and nodal status assessment in pancreaticoduodenectomy for pancreatic adenocarcinoma. Co-author DOI 10.1016/j.ejso.2013.07.089↗
- Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma. Co-author DOI 10.1053/j.gastro.2012.06.006↗
- Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma. Co-author DOI 10.1093/annonc/mdr617↗
Closest collaborators
The 25 strongest of 67 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jean‐Baptiste Bachet · 20 shared papers, 2012–2024 · strength 1.78
- Paper Trop-2 is a ubiquitous and promising target in pancreatic adenocarcinoma. DOI 10.1016/j.clinre.2023.102108↗
- Paper Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review o… DOI 10.3390/ijms22136756↗
- Paper Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic… DOI 10.1038/s41467-023-39026-y↗
- Jerome F. Cros · 17 shared papers, 2013–2024 · strength 1.70
- Paper Trop-2 is a ubiquitous and promising target in pancreatic adenocarcinoma. DOI 10.1016/j.clinre.2023.102108↗
- Paper Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review o… DOI 10.3390/ijms22136756↗
- Paper Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic… DOI 10.1038/s41467-023-39026-y↗
- Rémy Nicolle · 10 shared papers, 2019–2024 · strength 1.20
- Paper Trop-2 is a ubiquitous and promising target in pancreatic adenocarcinoma. DOI 10.1016/j.clinre.2023.102108↗
- Paper Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic… DOI 10.1038/s41467-023-39026-y↗
- Paper Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma. DOI 10.1038/s41591-023-02790-x↗
- Pascal R. Hammel · 12 shared papers, 2012–2023 · strength 0.96
- Paper Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic… DOI 10.1038/s41467-023-39026-y↗
- Paper Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resecte… DOI 10.1016/j.ejca.2021.01.042↗
- Paper Ovarian metastases of pancreatic adenocarcinoma: clinical presentation, role of surgery, and potential value of the mut… DOI 10.1177/17588359211053412↗
- Louis de Mestier · 6 shared papers, 2019–2024 · strength 0.70
- Paper Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic… DOI 10.1038/s41467-023-39026-y↗
- Paper Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma. DOI 10.1038/s41591-023-02790-x↗
- Paper Prognostic Relevance of Pancreatic Adenocarcinoma Whole-Tumor Transcriptomic Subtypes and Components. DOI 10.1158/1078-0432.ccr-21-1907↗
- Vinciane Rebours · 5 shared papers, 2021–2023 · strength 0.66
- Paper Trop-2 is a ubiquitous and promising target in pancreatic adenocarcinoma. DOI 10.1016/j.clinre.2023.102108↗
- Paper Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic… DOI 10.1038/s41467-023-39026-y↗
- Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
- Jean‐Luc Van Laethem · 8 shared papers, 2012–2023 · strength 0.64
- Paper Trop-2 is a ubiquitous and promising target in pancreatic adenocarcinoma. DOI 10.1016/j.clinre.2023.102108↗
- Paper Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resecte… DOI 10.1016/j.ejca.2021.01.042↗
- Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
- Francesco Puleo · 6 shared papers, 2015–2022 · strength 0.55
- Paper Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resecte… DOI 10.1016/j.ejca.2021.01.042↗
- Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
- Paper Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features. DOI 10.3390/cancers13061234↗
- Juan Iovanna · 4 shared papers, 2021–2023 · strength 0.45
- Paper Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic… DOI 10.1038/s41467-023-39026-y↗
- Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
- Paper PACpAInt: a deep learning approach to identify molecular subtypes of pancreatic adenocarcinoma on histology slides DOI 10.1101/2022.01.04.474951↗
- Nelson Dusetti · 4 shared papers, 2021–2023 · strength 0.45
- Paper Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic… DOI 10.1038/s41467-023-39026-y↗
- Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
- Paper PACpAInt: a deep learning approach to identify molecular subtypes of pancreatic adenocarcinoma on histology slides DOI 10.1101/2022.01.04.474951↗
- Valérie Paradis · 4 shared papers, 2019–2023 · strength 0.42
- Paper Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic… DOI 10.1038/s41467-023-39026-y↗
- Paper PACpAInt: a deep learning approach to identify molecular subtypes of pancreatic adenocarcinoma on histology slides DOI 10.1101/2022.01.04.474951↗
- Paper Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features. DOI 10.3390/cancers13061234↗
- Thierry André · 7 shared papers, 2012–2021 · strength 0.40
- Paper Pancreatic ductal adenocarcinoma harboring microsatellite instability / DNA mismatch repair deficiency. Towards persona… DOI 10.1016/j.suronc.2018.11.019↗
- Paper Ovarian metastases of pancreatic adenocarcinoma: clinical presentation, role of surgery, and potential value of the mut… DOI 10.1177/17588359211053412↗
- Paper Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With… DOI 10.1097/mpa.0000000000000394↗
- Léo Mas · 2 shared papers, 2021–2023 · strength 0.35
- Raphaël Maréchal · 8 shared papers, 2012–2019 · strength 0.34
- Paper hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status. DOI 10.3390/cancers11111808↗
- Paper Human equilibrative nucleoside transporter 1 testing in pancreatic ductal adenocarcinoma: a comparison between murine a… DOI 10.1111/his.12577↗
- Paper Lysyl oxidase family activity promotes resistance of pancreatic ductal adenocarcinoma to chemotherapy by limiting the i… DOI 10.18632/oncotarget.8527↗
- Tatjana Arsenijevic · 3 shared papers, 2021–2022 · strength 0.33
- Paper Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resecte… DOI 10.1016/j.ejca.2021.01.042↗
- Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
- Paper A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma. DOI 10.1016/j.annonc.2020.10.601↗
- Pierre Laurent‐Puig · 3 shared papers, 2019–2024 · strength 0.33
- Paper Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma. DOI 10.1038/s41591-023-02790-x↗
- Paper Prognostic Relevance of Pancreatic Adenocarcinoma Whole-Tumor Transcriptomic Subtypes and Components. DOI 10.1158/1078-0432.ccr-21-1907↗
- Paper hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status. DOI 10.3390/cancers11111808↗
- Renato Micelli Lupinacci · 3 shared papers, 2013–2021 · strength 0.32
- Paper Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review o… DOI 10.3390/ijms22136756↗
- Paper Pancreatic ductal adenocarcinoma harboring microsatellite instability / DNA mismatch repair deficiency. Towards persona… DOI 10.1016/j.suronc.2018.11.019↗
- Paper Number of examined lymph nodes and nodal status assessment in pancreaticoduodenectomy for pancreatic adenocarcinoma. DOI 10.1016/j.ejso.2013.07.089↗
- François Paye · 6 shared papers, 2012–2021 · strength 0.27
- Paper Ovarian metastases of pancreatic adenocarcinoma: clinical presentation, role of surgery, and potential value of the mut… DOI 10.1177/17588359211053412↗
- Paper Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinoma. DOI 10.1158/1078-0432.ccr-14-0667↗
- Paper Number of examined lymph nodes and nodal status assessment in pancreaticoduodenectomy for pancreatic adenocarcinoma. DOI 10.1016/j.ejso.2013.07.089↗
- Shulin Zhao · 2 shared papers, 2021–2024 · strength 0.25
- Cindy Neuzillet · 2 shared papers, 2022–2023 · strength 0.24
- Paper Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic… DOI 10.1038/s41467-023-39026-y↗
- Paper PACpAInt: a deep learning approach to identify molecular subtypes of pancreatic adenocarcinoma on histology slides DOI 10.1101/2022.01.04.474951↗
- Charlie Saillard · 2 shared papers, 2022–2023 · strength 0.24
- Paper Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic… DOI 10.1038/s41467-023-39026-y↗
- Paper PACpAInt: a deep learning approach to identify molecular subtypes of pancreatic adenocarcinoma on histology slides DOI 10.1101/2022.01.04.474951↗
- Magali Richard · 2 shared papers, 2022–2023 · strength 0.24
- Paper Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic… DOI 10.1038/s41467-023-39026-y↗
- Paper PACpAInt: a deep learning approach to identify molecular subtypes of pancreatic adenocarcinoma on histology slides DOI 10.1101/2022.01.04.474951↗
- Anne Couvelard Benveniste · 4 shared papers, 2012–2021 · strength 0.22
- Paper Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features. DOI 10.3390/cancers13061234↗
- Paper hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status. DOI 10.3390/cancers11111808↗
- Paper Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in res… DOI 10.1093/annonc/mdr617↗
- Pieter Demetter · 6 shared papers, 2012–2015 · strength 0.21
- Paper Human equilibrative nucleoside transporter 1 testing in pancreatic ductal adenocarcinoma: a comparison between murine a… DOI 10.1111/his.12577↗
- Paper Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With… DOI 10.1097/mpa.0000000000000394↗
- Paper Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinoma. DOI 10.1158/1078-0432.ccr-14-0667↗
- Julie Roques · 2 shared papers, 2021–2022 · strength 0.21
- Paper Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict a… DOI 10.1016/j.tranon.2021.101315↗
- Paper A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma. DOI 10.1016/j.annonc.2020.10.601↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.